Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1356-1363, 2004; 10.1373/clinchem.2003.029868
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grebenchtchikov, N.
Right arrow Articles by Dorssers, L. C.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grebenchtchikov, N.
Right arrow Articles by Dorssers, L. C.J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Cancer Diagnostics (since 2002)
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2004;50:1356-1363.)
© 2004 American Association for Clinical Chemistry, Inc.

Cancer Diagnostics

Development of an ELISA for Measurement of BCAR1 Protein in Human Breast Cancer Tissue

Nicolai Grebenchtchikov1, Arend Brinkman2, Simone P.J. van Broekhoven2, Danielle de Jong2, Anneke Geurts-Moespot1, Paul N. Span1, Harry A. Peters3, Henk Portengen3, John A. Foekens3, C.G.J. (Fred) Sweep1,a and Lambert C.J. Dorssers2

1 Department of Chemical Endocrinology, University Medical Center Nijmegen, Nijmegen, The Netherlands. 2 Department of Pathology, Division of Molecular Biology, and 3 Department of Medical Oncology, Erasmus MC Rotterdam, Rotterdam, The Netherlands.

aAddress correspondence to this author at: Department of Chemical Endocrinology, University Medical Centre Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. Fax 31-243541484; e-mail F.Sweep{at}ace.umcn.nl.

Background: High concentrations of breast cancer anti-estrogen resistance 1 (BCAR1) protein measured by Western blotting in primary breast tumor cytosols are associated with early disease progression and failure of tamoxifen therapy. The aim of the present study was to develop an ELISA to measure BCAR1 quantitatively in extracts of human breast cancer tissue.

Methods: A recombinant fragment of BCAR1 (the human homolog of murine p130Cas) was produced in bacterial M15 cells, purified, and injected into chickens and rabbits. The generated antibodies were affinity-purified and used for the construction of an ELISA. After validation, the results obtained with the ELISA were compared with Western blot findings on primary breast tumors.

Results: The detection limit the BCAR1 ELISA was 0.0031 µg/L, and the within-run imprecision (CV) was <20% at concentrations down to 0.004 µg/L. The within-run imprecision (CV) was 1.0–7.2%, and the between-run CV was 3.6–5.4%. There was no cross-reactivity with family member HEF1. The assay exhibited parallelism of results between serial dilutions and a mean recovery (range) of 96 (79–118)%.

Conclusions: The ELISA measures BCAR1 in human breast cancer cytosols with high sensitivity and specificity. The assay can be used to confirm and to quantitatively extend previous semiquantitative Western blot data on the prognostic and predictive value of BCAR1 in human breast cancer; it can also be applied for other diseases.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
L. C.J. Dorssers, N. Grebenchtchikov, A. Brinkman, M. P. Look, J. G.M. Klijn, A. Geurts-Moespot, P. N. Span, J. A. Foekens, and C.G.J. Sweep
Application of a Newly Developed ELISA for BCAR1 Protein for Prediction of Clinical Benefit of Tamoxifen Therapy in Patients with Advanced Breast Cancer
Clin. Chem., August 1, 2004; 50(8): 1445 - 1447.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.